FIREFLY NEUROSCIENCE, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.1M | $108,000 | $498,000 | $12.0M | $15.0M |
| Cost of revenue | $497,000 | $0 | — | — | $11.4M |
| Gross profit | $645,000 | $108,000 | $2.6M | $2.9M | $3.6M |
| Selling, general & administrative | — | — | $5.8M | $8.3M | $6.2M |
| Research and development | $1.5M | $2.0M | $741,000 | — | — |
| Operating expenses | $9.5M | $10.2M | $3.6M | — | — |
| Operating income | -$8.9M | -$10.1M | -$3.1M | -$5.4M | -$2.6M |
| Interest expense | — | — | $103,256 | $81,621 | $37,325 |
| Pretax income | -$19.9M | -$10.5M | -$2.6M | -$5.5M | -$2.2M |
| Income tax expense | $5,000 | -$2,000 | $1,000 | $812,457 | -$1.1M |
| Net income | -$19.9M | -$10.5M | -$2.6M | -$17.8M | -$1.1M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | $681,995 | $731,081 | $4.9M |
| Current assets | $4.0M | $2.6M | $2.3M | $2.8M | $6.9M |
| Total assets | $10.5M | $4.6M | $2.6M | $8.0M | $23.4M |
| Current liabilities | $2.8M | $5.0M | $2.5M | $3.9M | $2.0M |
| Total liabilities | $2.8M | $5.0M | $2.5M | $4.3M | $5.9M |
| Stockholders' equity | $7.6M | -$375,000 | $109,000 | -$2.2M | $17.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$8.2M | -$6.2M | -$2.2M | -$6.0M | -$735,015 |
| Depreciation and amortization | $172,000 | $67,000 | $0 | $219,986 | $236,598 |
| Stock-based compensation | $749,000 | $2.6M | $295,000 | $1.3M | $1.9M |
| Capital expenditure | — | — | $0 | $535,902 | $69,754 |
| Free cash flow | — | — | -$2.2M | -$6.5M | -$804,769 |
| Share repurchases | — | — | $0 | — | — |
| Impairments | — | — | — | $6.5M | $0 |
Shares outstanding 15.6M · Free float 56.5%
Annual filing data through FY ended December 31, 2025; float as of July 10, 2026.